Malkasian G D, Melton L J, O'Brien P C, Greene M H
Am J Obstet Gynecol. 1984 Jun 1;149(3):274-84. doi: 10.1016/0002-9378(84)90227-8.
Overall survival in 1938 women with epithelial ovarian cancer receiving primary treatment at Mayo Clinic was 35% at 5 years, 28% at 10 years, and 15% at 25 years. For most histologic cell types, observed differences in survival were more apparent than real since the behavior of different cell types was similar when compared stage for stage and grade for grade. Mucinous cystadenocarcinomas tended to be low grade and low stage, while serous cystadenocarcinomas tended to be high grade and high stage. For Stage I disease, factors other than cell type seemed to be more important in determining survival; specifically, Stage IA1 patients did significantly better than all other Stage I patients. In Stage III disease, the amount of residual tumor made a significant difference in survival for all grades. In Stage IV disease, the amount of residual made a highly significant difference in survival for grade 1 disease.
在梅奥诊所接受初始治疗的1938例上皮性卵巢癌女性患者中,5年总生存率为35%,10年为28%,25年为15%。对于大多数组织学细胞类型而言,观察到的生存差异更多是表面的,因为在逐期和逐分级比较时,不同细胞类型的行为相似。黏液性囊腺癌往往分级低、分期低,而浆液性囊腺癌往往分级高、分期高。对于Ⅰ期疾病,细胞类型以外的因素在决定生存方面似乎更为重要;具体而言,ⅠA1期患者的生存情况明显优于所有其他Ⅰ期患者。在Ⅲ期疾病中,残留肿瘤量对所有分级的生存均有显著影响。在Ⅳ期疾病中,残留量对1级疾病的生存有高度显著影响。